Wedbush Securities' Kelly Lisbakken Promoted to Managing Director, Investment Banking

20:00 EDT 6 Aug 2015 | Globe Newswire

SAN FRANCISCO, Aug. 7, 2015 (GLOBE NEWSWIRE) -- Wedbush Securities, one of the nation's leading diversified financial services firms, is pleased to announce the promotion of Kelly Lisbakken to Managing Director in the Healthcare Investment Banking Group. Kelly is based in the firm's San Francisco office and focuses primarily on covering biotechnology and specialty pharmaceuticals companies.

Since Kelly joined Pacific Growth Equities in 2004, she has completed over 130 transactions, raising over $11 billion. Prior to joining Wedbush, Kelly worked on Cialis and the PDE4 program at ICOS Corporation (now Eli Lilly and Company). She holds a Bachelor of Arts degree in Molecular Biology from Princeton University.
"Since first joining Pacific Growth Equities and through its acquisition to become Wedbush PacGrow Healthcare, Kelly has been a key member of the investment banking team," states Scott T. Smith, Director of Healthcare Investment Banking. "I am pleased to recognize Kelly's achievement, and her creativity and tenacity in supporting her clients."
The Wedbush Capital Markets group offers a wide range of products and services to corporate and institutional clients, which include equity, equity-linked and leverage financing, strategic advisory services, equity research, and market making and clearing services. The Wedbush Investment Banking Group, a division of Capital Markets, is composed of senior, industry-focused professionals who have extensive transactional backgrounds, long-standing industry relationships, and are dedicated to playing an active role in every transaction. The group evaluates and executes complex transactions that create long-term shareholder value.

About Wedbush Securities

Since our founding in 1955, Wedbush has been a leader in the financial industry providing our clients with a wide range of services; including retail and institutional sales, clearing services, equity research, corporate and municipal finance, equity market making, fixed income trading, and wealth management. Headquartered in Los Angeles, with over 100 registered offices, the firm focuses on relentless service, client financial safety, continuity, and advanced technology. Wedbush Securities is the largest subsidiary of holding company WEDBUSH, Inc., which also includes affiliated firms Wedbush Asset Management, Wedbush Capital Partners, Wedbush Opportunity Partners, and Lime Brokerage LLC.
Follow us on Twitter @Wedbush.

CONTACT: Teny Josephbek

More From BioPortfolio on "Wedbush Securities' Kelly Lisbakken Promoted to Managing Director, Investment Banking"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Erectile Dysfunction
Erectile dysfunction (ED or impotence) is the inability to get and maintain an erection that is sufficient for satisfactory sexual intercourse, and affects half of all men between the ages of 40 to 70. The causes of ED can be both physical and psycholo...